Bluegrass Vascular

Executive Summary

Bluegrass Vascular is a private medical device company focused on improving vascular access for patients requiring hemodialysis, chemotherapy, and nutrition. Founded in 2010 by Dr. John Gurley and headquartered in San Antonio, Texas, the company developed the Surfacer® Inside-Out® Access Catheter System, which addresses the limitations of traditional central venous access in patients with central venous occlusions. The device enables catheter placement via a unique inside-out technique, reducing risks associated with conventional approaches. With FDA approval and CE marking, the Surfacer system is commercially available in the U.S. and Europe, targeting a significant unmet need in patients who have exhausted standard access options. The company's innovative technology has the potential to improve clinical outcomes and reduce complications, positioning it as a key player in the vascular access market. The company's commercial traction and regulatory approvals provide a foundation for growth. However, as a private entity with limited public financial disclosures, the investment thesis hinges on adoption rates and partnership development. Bluegrass Vascular's ability to capture market share in the dialysis and oncology settings will determine its long-term value. Ongoing efforts to expand clinical evidence and secure reimbursement in key markets are critical. With a novel solution for a challenging clinical problem, the company is well-positioned for sustained success, but execution risks remain.

Upcoming Catalysts (preview)

• Q4 2026Landmark clinical study publication or registry data demonstrating improved outcomes60% success
• Q2 2027Strategic partnership or distribution agreement with a major medical device company45% success
• Q3 2026Expansion into new geographic markets or indications (e.g., pediatric or oncology)50% success